Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Na-APR-1 and Na-GST-1 hookworm vaccine in Brazilian adults
NCT02476773Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Na-APR-1 (M74) + Alhydrogel and Na-GST-1/Alhydrogel in hookworm infection, sponsored by Baylor College of Medicine. Started Jan 2016; status: completed.
02
Drugs
Na-APR-1 (M74) + AlhydrogelNa-GST-1/Alhydrogel
03
Conditions
hookworm infection
Beyond the preview
Go deeper on NCT02476773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476773.